Solace Lifesciences, Inc. — Form D

Solace Lifesciences, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2010-10-06. The offering totals $2.0M, of which $50K was reported sold. Industry: Other Health Care.

Offering

Filed: 2010-10-06
Form: D
Accession: 0001502380-10-000001
Industry: Other Health Care
Exemptions: 05
Total offering: $2.0M
Amount sold: $50K
Remaining: $1.9M
Minimum investment: $25K
Investors: 2
Date of first sale: 2010-09-27
Security types: debt
Revenue range: $1 - $1,000,000
SEC file number: 021-148662

Issuer

Name: Solace Lifesciences, Inc.
CIK: 0001502380
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2010
Address: 501 SILVERSIDE ROAD #7, WILMINGTON, DE, 19809
Phone: 877-668-2256

Officers, directors & promoters (13)

Name	Role	Location
David C Allen	Director	Kerrville, TX
James M Poole	Director	Wilmington, DE
James M Poole	Executive Officer	Wilmington, DE
Stephen G Kujawa	Director	Wilmington, DE
David G Pilzner	Director	Wilmington, DE
Christopher G Gross	Director	Wilmington, DE
Christopher G Gross	Executive Officer	Wilmington, DE
Garrett G Holloway	Director	Wilmington, DE
Christopher C Gross	Director	Wilmington, DE
Christopher C Gross	Executive Officer	Wilmington, DE
Garrett C Holloway	Director	Wilmington, DE
David C Pilzner	Director	Wilmington, DE
Stephen C Kujawa	Director	Wilmington, DE

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2018-12-07	D	$5.0M	—
2017-12-14	D/A	$4.0M	$1.6M
2015-05-01	D	$4.0M	—

More